14 Sep Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
Posted at 21:34h
in Author Interviews, Boehringer Ingelheim, Columbia, Heart Disease, J&J-Janssen, Merck, NEJM
MedicalResearch.com Interview with: Professor Christopher P. Cannon MD Executive Director, Cardiometabolic Trials, Baim Institute Cardiologist Brigham and Women’s Hospital Baim...